Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.
about
Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndromeSafety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coliSerotypes, intimin variants and other virulence factors of eae positive Escherichia coli strains isolated from healthy cattle in Switzerland. Identification of a new intimin variant gene (eae-eta2).Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposalShiga Toxin (Stx) Classification, Structure, and FunctionPurification and characterization of Shiga toxin 2f, an immunologically unrelated subtype of Shiga toxin 2Identification of Human-Pathogenic Strains of Shiga Toxin-Producing Escherichia coli from Food by a Combination of Serotyping and Molecular Typing of Shiga Toxin GenesProtection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.Intracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody.Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls.Phylogenetic analysis of Shiga toxin 1 and Shiga toxin 2 genes associated with disease outbreaks.Interaction of the verotoxin 1B subunit with soluble aminodeoxy analogues of globotriaosyl ceramides.Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease.Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany.Virulence factors for hemolytic uremic syndrome, DenmarkAntibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.Distribution of the urease gene cluster among and urease activities of enterohemorrhagic Escherichia coli O157 isolates from humansAntimicrobial treatment of asymptomatic carriers of verocytotoxin-producing Escherichia coli: an empiric study.stx2vha is the dominant genotype of Shiga toxin-producing Escherichia coli O157:H7 isolated from patients and domestic animals in three regions of China.Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157: indications for an animal reservoir.Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM.Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity.The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestationsPrevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.Molecular analysis of shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients and dairy samples in France.Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome.Hemolytic uremic syndrome: pathogenesis and update of interventions.Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections.Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease.Outbreak of Shiga toxin-producing Escherichia coli (STEC) O104:H4 infection in Germany causes a paradigm shift with regard to human pathogenicity of STEC strains.Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice.A novel murine infection model for Shiga toxin-producing Escherichia coli.Neonatal hemolytic uremic syndrome after mother-to-child transmission of a low-pathogenic stx2b harboring shiga toxin-producing Escherichia coli.Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center[Evolution and infection biology of hemolytic-uremic syndrome (HUS) associated E. coli (HUSEC)].Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.Verocytotoxin-producing Escherichia coli O128ab:H2 bacteremia in a 27-year-old male with hemolytic-uremic syndrome.Multistate outbreak of Escherichia coli O145 infections associated with romaine lettuce consumption, 2010.
P2860
Q24306498-AF94924E-9278-447B-A9AB-09EA2FF662D0Q24653814-68206113-CE02-4C5D-9246-C1333F617936Q24810190-2B6A6884-BE7F-4651-ABEF-956E6DE4D608Q26827657-417994A7-406A-4047-BE75-115B513B97BAQ27021676-9EAE335B-CF4D-49D0-AA17-355F7B298239Q28488900-53E17249-A071-4394-B4B7-363F02127DFAQ29040822-D86FEB77-0F1B-41F9-A171-F54EDECDBEBFQ30418998-9C717990-94FC-43FA-BB15-B8317A18EB52Q30481790-EE1DCA22-C995-43ED-AE95-C49AF83D825BQ31165106-927705AC-5BA1-4B88-8506-4E131CDBB072Q33308321-B7697473-1377-4C6B-A810-32452593A7CFQ33343700-1125969A-54AD-475A-B791-52D282FC3092Q33346383-E520CDFB-985B-445E-B96F-98AA020F7734Q33348352-F9689222-FDCE-475B-A36D-552F93F8AE4DQ33359875-AB78443C-60AC-4C63-8FFE-F0F7739D50D6Q33361309-FD4A71A6-412B-48D7-86A2-77548B42594DQ33363266-9858386F-5427-47E3-AA8B-1059A4179E0DQ33364864-860AE51C-B393-43CD-8153-AFF6F174ECE6Q33365366-35710D37-E444-49E2-976C-4400C6CA6EECQ33369655-B8822BCE-904B-49F3-8015-59F9DCD45C96Q33369701-3D752F47-DDBF-43B2-9F31-F2A5EB8E7073Q33370432-5B4C262B-DC2F-4D5A-B1E7-425BD67F4749Q33371092-CADEB8ED-B1BF-45C6-A85E-6ECBC3E1BCEDQ33373301-0E32632F-6B36-4BED-A1F0-36CB2CF4DECEQ33374948-76694A90-950F-4D11-B2B0-1837D3AB8AD5Q33375505-1EF208F9-EA60-4A74-92D8-08EDF13E81E6Q33378526-9FDE79E2-EF5C-4922-B65C-7C0E71DD6025Q33379683-36E77089-2846-489A-BED2-9CA2EB482736Q33385809-FB12BB58-10F5-413A-B151-81158C426BC8Q33389308-5B077FE8-C742-4E7C-8D1B-11585E470C17Q33396843-6BEF6CF1-6596-4E58-9C42-72CF8C7ABDBBQ33399393-FF2D50E3-6891-4742-BAE1-261BE388FFBAQ33401560-7A986D0C-61C2-4328-9BBE-8E1F34367580Q33403695-31536E78-DFFF-4600-9034-1B69765348B3Q33403700-66E0F186-22C6-48F7-A745-B934FB691ADCQ33404523-F4E04B41-0F4E-4D34-8955-7F93A004A7F6Q33405030-18C93C83-12C7-4468-8443-6CF4FBB137E0Q33405827-00882930-E21A-456F-8B4F-76A7A0A063DFQ33406297-F34F908D-13E5-4A99-A1AF-D7B94C5CEE92Q33408119-E502A62C-5D18-45F1-9AF1-0815D757803A
P2860
Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Escherichia coli harboring Shi ...... iation with clinical symptoms.
@ast
Escherichia coli harboring Shi ...... iation with clinical symptoms.
@en
type
label
Escherichia coli harboring Shi ...... iation with clinical symptoms.
@ast
Escherichia coli harboring Shi ...... iation with clinical symptoms.
@en
prefLabel
Escherichia coli harboring Shi ...... iation with clinical symptoms.
@ast
Escherichia coli harboring Shi ...... iation with clinical symptoms.
@en
P2093
P356
P1476
Escherichia coli harboring Shi ...... iation with clinical symptoms.
@en
P2093
Alexander W Friedrich
Martina Bielaszewska
Matthias Pulz
Thorsten Kuczius
Wen-Lan Zhang
P356
10.1086/338115
P407
P577
2001-12-14T00:00:00Z